ATP-binding cassette transporter A1 and HDL metabolism: Effects of fatty acids

Journal of Nutritional Biochemistry

Volumn 23, Issue 1, 2012, Pages 1-7

  Lee, Jiyoung ^a   Park, Youngki ^a   Koo, Sung I ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

ATP binding cassette transporter A1; Fatty acids; High density lipoprotein; Regulation

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CHOLESTEROL; CYCLIC AMP DEPENDENT PROTEIN KINASE; FATTY ACID; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTONE DEACETYLASE; LIVER X RECEPTOR; PHOSPHOLIPID; PROTEASOME; PROTEIN KINASE; SATURATED FATTY ACID; UNSATURATED FATTY ACID;

CHOLESTEROL BLOOD LEVEL; DEACETYLATION; FAT INTAKE; HUMAN; LIPOPROTEIN METABOLISM; METABOLIC REGULATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SUMOYLATION; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION; UBIQUITINATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL, HDL; DIETARY FATS; FATTY ACIDS; HUMANS; LIPOPROTEINS, HDL;

EID: 83355163298     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.03.001     Document Type: Review

References (97)

1. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989, 79:8-15.
2. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977, 62:707-714.
3. Miller N.E. The evidence for the antiatherogenicity of high density lipoprotein in man. Lipids 1978, 13:914-919.
4. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995, 36:211-228.
5. Barter P.J. Inhibition of endothelial cell adhesion molecule expression by high density lipoproteins. Clin Exp Pharmacol Physiol 1997, 24:286-287.
6. Parthasarathy S., Barnett J., Fong L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990, 1044:275-283.
7. Glomset J.A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 1968, 9:155-167.
8. Pieters M.N., Schouten D., Van Berkel T.J. In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim Biophys Acta 1994, 1225:125-134.
9. Anderson D.W., Nichols A.V., Forte T.M., Lindgren F.T. Particle distribution of human serum high density lipoproteins. Biochim Biophys Acta 1977, 493:55-68.
10. Blanche P.J., Gong E.L., Forte T.M., Nichols A.V. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 1981, 665:408-419.
11. Noble R.P., Hatch F.T., Mazrimas J.A., Lindgren F.T., Jensen L.C., Adamson G.L. Comparison of lipoprotein analysis by agarose gel and paper electrophoresis with analytical ultracentrifugation. Lipids 1969, 4:55-59.
12. Cheung M.C., Albers J.J. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem 1984, 259:12201-12209.
13. Schaefer E.J., Zech L.A., Jenkins L.L., Bronzert T.J., Rubalcaba E.A., Lindgren F.T., et al. Human apolipoprotein A-I and A-II metabolism. J Lipid Res 1982, 23:850-862.
14. Jauhiainen M., Metso J., Pahlman R., Blomqvist S., van Tol A., Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993, 268:4032-4036.
15. Pussinen P., Jauhianinen M., Metso J., Tyynela J., Ehnholm C. Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res 1995, 36:975-985.
16. Tu A.Y., Nishida H.I., Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 1993, 268:23098-23105.
17. Thuren T. Hepatic lipase and HDL metabolism. Curr Opin Lipidol 2000, 11:277-283.
18. Ha Y.C., Gorjatschko L., Barter P.J. Changes in the density distribution of pig high density lipoproteins during incubation in vitro. Influence of esterified cholesterol transfer activity. Atherosclerosis 1983, 48:253-263.
19. Kunitake S.T., Mendel C.M., Hennessy L.K. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res 1992, 33:1807-1816.
20. Keys A. Effects of different dietary fats on plamsa lipid levels. Lancet 1965, 1:318-319.
21. Hegsted D., McGandy R.B., Myers M.L., Stare F.J. Quantative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965, 17:281-293.
22. Francone O.L., Subbaiah P.V., van Tol A., Royer L., Haghpassand M. Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1. Biochemistry (Mosc) 2003, 42:8569-8578.
23. McNeish J., Aiello R.J., Guyot D., Turi T., Gabel C., Aldinger C., et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci U S A 2000, 97:4245-4250.
24. Parks J.S., Rudel L.L. Effect of fish oil on atherosclerosis and lipoprotein metabolism. Atherosclerosis 1990, 84:83-94.
25. Harris W.S. n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 1996, 31:243-252.
26. Johnson F.L., Babiak J., Rudel L.L. High density lipoprotein accumulation in perfusates of isolated livers of African green monkeys. Effects of saturated versus polyunsaturated dietary fat. J Lipid Res 1986, 27:537-548.
27. Mensink R.P., Zock P.L., Kester A.D.M., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77:1146-1155.
28. Hegsted D.M., Ausman L.M., Johnson J.A., Dallal G.E. Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr 1993, 57:875-883.
29. Mensink R.P., Katan M.B. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992, 12:911-919.
30. Kris-Etherton P.M., Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr 1997, 65:1628S-1644S.
31. Howell W.H., McNamara D.J., Tosca M.A., Smith B.T., Gaines J.A. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am J Clin Nutr 1997, 65:1747-1764.
32. Kralova Lesna I., Suchanek P., Kovar J., Stavek P., Poledne R. Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport. J Lipid Res 2008, 49:2414-2418.
33. Fredrickson D.S., Altrocchi P.H., Avioli L.V., Goodman D.S., Goodman H.C. Tangier disease. Ann Intern Med 1961, 55:1016-1031.
34. Serfaty-Lacrosniere C., Civeira F., Lanzberg A., Isaia P., Berg J., Janus E.D., et al. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 1994, 107:85-98.
35. Oram J.F. Tangier disease and ABCA1. Biochim Biophys Acta 2000, 1529:321-330.
36. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999, 22:347-351.
37. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999, 22:336-345.
38. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C., et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999, 22:352-355.
39. Luciani M.F., Denizot F., Savary S., Mattei M.G., Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 1994, 21:150-159.
40. Castro G.R., Fielding C.J. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry (Mosc) 1988, 27:25-29.
41. Huang Y., von Eckardstein A., Assmann G. Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb 1993, 13:445-458.
42. Forte T.M., Goth-Goldstein R., Nordhausen R.W., McCall M.R. Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J Lipid Res 1993, 34:317-324.
43. Forte T.M., Bielicki J.K., Knoff L., McCall M.R. Structural relationships between nascent apoA-I-containing particles that are extracellularly assembled in cell culture. J Lipid Res 1996, 37:1076-1085.
44. Bielicki J.K., McCall M.R., Forte T.M. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells. J Lipid Res 1999, 40:85-92.
45. Francis G.A., Knopp R.H., Oram J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest 1995, 96:78-87.
46. Takahashi Y., Smith J.D. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. Proc Natl Acad Sci U S A 1999, 96:11358-11363.
47. Liu L., Bortnick A.E., Nickel M., Dhanasekaran P., Subbaiah P.V., Lund-Katz S., et al. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles. J Biol Chem 2003, 278:42976-42984.
48. Mulya A., Lee J.Y., Gebre A.K., Thomas M.J., Colvin P.L., Parks J.S. Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1. Arterioscler Thromb Vasc Biol 2007, 27:1828-1836.
49. Mulya A., Lee J.Y., Gebre A.K., Boudyguina E.Y., Chung S.K., Smith T.L., et al. Initial interaction of ApoA-I with ATP binding cassette transporter A1 (ABCA1) impacts in vivo metabolic fate of nascent HDL. J Lipid Res 2008, 49:2390-2401.
50. Vaisman B.L., Lambert G., Amar M., Joyce C., Ito T., Shamburek R.D., et al. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest 2001, 108:303-309.
51. Haghpassand M., Bourassa P.A., Francone O.L., Aiello R.J. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 2001, 108:1315-1320.
52. Basso F., Freeman L., Knapper C.L., Remaley A., Stonik J., Neufeld E.B., et al. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J Lipid Res 2003, 44:296-302.
53. Wellington C.L., Brunham L.R., Zhou S., Singaraja R.R., Visscher H., Gelfer A., et al. Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1. J Lipid Res 2003, 44:1470-1480.
54. Murthy S., Born E., Mathur S.N., Field F.J. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells. J Lipid Res 2002, 43:1054-1064.
55. Brunham L.R., Kruit J.K., Iqbal J., Fievet C., Timmins J.M., Pape T.D., et al. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest 2006, 116:1052-1062.
56. Zhu X., Lee J.Y., Timmins J.M., Brown J.M., Boudyguina E., Mulya A., et al. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem 2008, 283:22930-22941.
57. Timmins J.M., Lee J.Y., Boudyguina E., Kluckman K.D., Brunham L.R., Mulya A., et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 2005, 115:1333-1342.
58. Lee J.Y., Parks J.S. ATP-binding cassette transporter AI and its role in HDL formation. Curr Opin Lipidol 2005, 16:19-25.
59. Naik S.U., Wang X., Da Silva J.S., Jaye M., Macphee C.H., Reilly M.P., et al. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 2006, 113:90-97.
60. Tontonoz P., Mangelsdorf D.J. Liver X. receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003, 17:985-993.
61. Costet P., Luo Y., Wang N., Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000, 275:28240-28245.
62. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A 2000, 97:12097-12102.
63. Wellington C.L., Walker E.K., Suarez A., Kwok A., Bissada N., Singaraja R., et al. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab Invest 2002, 82:273-283.
64. Arakawa R., Yokoyama S. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J Biol Chem 2002, 277:22426-22429.
65. Oram J.F., Lawn R.M., Garvin M.R., Wade D.P. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000, 275:34508-34511.
66. Wang N., Chen W., Linsel-Nitschke P., Martinez L.O., Agerholm-Larsen B., Silver D.L., et al. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest 2003, 111:99-107.
67. Martinez L.O., Agerholm-Larsen B., Wang N., Chen W., Tall A.R. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J Biol Chem 2003, 278:37368-37374.
68. Arakawa R., Hayashi M., Remaley A.T., Brewer B.H., Yamauchi Y., Yokoyama S. Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides. J Biol Chem 2004, 279:6217-6220.
69. Uehara Y., Engel T., Li Z., Goepfert C., Rust S., Zhou X., et al. Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 2002, 51:2922-2928.
70. Mauerer R., Ebert S., Langmann T. High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages. Exp Mol Med 2009, 41:126-132.
71. de Vogel van den Bosch H.M., de Wit N.J.W., Hooiveld G.J.E.J., Vermeulen H., van der Veen J.N., Houten S.M., et al. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine. Am J Physiol-Gastrointest Liver Physiol 2008, 294:G1171-G1180.
72. Ontsouka C.E., Burgener I.A., Mani O., Albrecht C. Polyunsaturated fatty acid-enriched diets used for the treatment of canine chronic enteropathies decrease the abundance of selected genes of cholesterol homeostasis. Domest Anim Endocrinol 2010, 38:32-37.
73. Uehara Y., Miura S.I., von Eckardstein A., Abe S., Fujii A., Matsuo Y., et al. Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 2007, 191:11-21.
74. Ku C.S., Park Y.K., Coleman S.L., Seo J.M., Lee J.Y. Regulation of ATP binding cassette transporter A1 (ABCA1) and ABCG1 by fatty acids in RAW 264.7 macrophages. FASEB J 2010, 24:924.3.
75. Roth S.Y., Denu J.M., Allis C.D. Histone acetyltransferases. Annu Rev Biochem 2001, 70:81-120.
76. Jones D.R., Divecha N. Linking lipids to chromatin. Curr Opin Genet Dev 2004, 14:196-202.
77. Guenther M.G., Lane W.S., Fischle W., Verdin E., Lazar M.A., Shiekhattar R. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev 2000, 14:1048-1057.
78. Zhang J., Kalkum M., Chait B.T., Roeder R.G. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 2002, 9:611-623.
79. Perissi V., Aggarwal A., Glass C.K., Rose D.W., Rosenfeld M.G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 2004, 116:511-526.
80. Lee S.K., Kim J.H., Lee Y.C., Cheong J., Lee J.W. Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor. J Biol Chem 2000, 275:12470-12474.
81. Baek S.H., Ohgi K.A., Rose D.W., Koo E.H., Glass C.K., Rosenfeld M.G. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 2002, 110:55-67.
82. Rosenfeld M.G., Glass C.K. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 2001, 276:36865-36868.
83. Naar A.M., Lemon B.D., Tjian R. Transcriptional coactivator complexes. Annu Rev Biochem 2001, 70:475-501.
84. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108:465-474.
85. Wagner B.L., Valledor A.F., Shao G., Daige C.L., Bischoff E.D., Petrowski M., et al. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol 2003, 23:5780-5789.
86. Brandl A., Heinzel T., Kramer O.H. Histone deacetylases: salesmen and customers in the post-translational modification market. Biol Cell 2009, 101:193-205.
87. Wang Y., Oram J.F. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 2002, 277:5692-5697.
88. Wang Y., Kurdi-Haidar B., Oram J.F. LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1. J Lipid Res 2004, 45:972-980.
89. Yang Y., Jiang Y., Wang Y., An W. Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells. Biochimie 2010, 92:958-963.
90. Murthy S., Born E., Mathur S.N., Field F.J. Liver-X-receptor-mediated increase in ATP-binding cassette transporter A1 expression is attenuated by fatty acids in CaCo-2 cells: effect on cholesterol efflux to high-density lipoprotein. Biochem J 2004, 377:545-552.
91. Wang Y., Oram J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J Biol Chem 2005, 280:35896-35903.
92. Wang Y., Oram J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J Lipid Res 2007, 48:1062-1068.
93. Hu Y.W., Ma X., Li X.X., Liu X.H., Xiao J., Mo Z.C., et al. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 2009, 204:e35-e43.
94. Park Y.K., Rasmussen H.E., Ehlers S.J., Ku C.S., Jesch E.D., Carr T.P., et al. Down-regulaiton of ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression by unsaturated fatty acids in vivo and in vitro. FASEB J 2008, 22:691.15.
95. Demaison L., Moreau D. Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci 2002, 59:463-477.
96. Schaefer E.J. Effects of dietary fatty acids on lipoproteins and cardiovascular disease risk: summary. Am J Clin Nutr 1997, 65:1655S-1656S.
97. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.